Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gotistobart Long-term Extension Study in Advanced Solid Tumors
NCT07659379Phase 3Enrolling by invitation
- Sponsor
- OncoC4
- Start
- Jul 2026
- Primary completion
- Jul 2036
- Countries
- 1
01
Overview
A Phase 3 trial of gotistobart in solid tumor (advanced stage), sponsored by OncoC4. Started Jul 2026; status: enrolling by invitation.
02
Drugs
gotistobart
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07659379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07659379.